E
Sol-Gel Technologies Ltd. SLGL
$0.7822 $0.00620.80% NASDAQ
Recommendation
Prev Close
$0.782207
Volume
43,793
Avg Vol (90D)
448,446
Market Cap
$21.79M
Dividend & Yield
--
52-Week Range
$0.334 - $1.65
P/E (TTM)
--
EPS (TTM)
-$0.312
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Sol-Gel Technologies (SLGL) Secures Licensing Deal, Eyes U.S. Market with SGT-610 MAYNF Stock News
4/17/2025 - GuruFocus
Sol-Gel, Mayne Pharma enter product purchase agreement
4/17/2025 - TipRanks Financial Blog
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S.
4/17/2025 - Globe Newswire
Investors Don't See Light At End Of Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Tunnel And Push Stock Down 31%
4/11/2025 - Simply Wall St
Sol-Gel Technologies (NASDAQ:SLGL) Stock Price Up 5.2% - Here's What Happened
3/29/2025 - Ticker Report
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update
2/12/2025 - Ticker Report
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Not Doing Enough For Some Investors As Its Shares Slump 51%
2/7/2025 - Simply Wall St
Is SolGel Technologies (SLGL) a Great Value Stock Right Now?
12/25/2024 - Zacks Investment Research
There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump
12/24/2024 - Simply Wall St
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
11/21/2024 - Simply Wall St
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know
11/20/2024 - Zacks Investment Research
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
11/20/2024 - Globe Newswire
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
11/15/2024 - Zacks Investment Research
Sol-Gel Technologies Reports Positive Q3 Financials and Strategic Moves
11/15/2024 - TipRanks Financial Blog
Sol-Gel Technologies reports Q3 EPS (1c) vs (23c) last year
11/15/2024 - The Fly
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/15/2024 - Globe Newswire
Analysis of ARMISTICE CAPITAL, LLC's Recent Transaction in Sol-Gel Technologies Ltd
11/15/2024 - GuruFocus
Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates
11/13/2024 - Zacks Investment Research
Paragon 28, Inc. (FNA) Reports Q3 Loss, Tops Revenue Estimates
11/12/2024 - Zacks Investment Research
Sol-Gel Technologies Appoints Interim CEO and Approves New Incentive Plan
11/4/2024 - TipRanks Financial Blog
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update
9/26/2024 - Ticker Report
Sol-Gel Technologies Announces Upcoming Special Meeting
9/25/2024 - TipRanks Financial Blog
SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
9/17/2024 - Zacks Investment Research
Sol-Gel Technologies (NASDAQ:SLGL) Trading Down 14.7%
9/10/2024 - Zolmax
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$42.01M
Total Debt (Q)
$1.39M
Total Liabilities (Q)
$7.10M
Book Value Per Share (Q)
$1.25
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, August 16, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
2.86
7-Day Total Return
62.96%
30-Day Total Return
40.66%
60-Day Total Return
1.58%
90-Day Total Return
63.13%
Year to Date Total Return
-22.94%
1-Year Total Return
-12.07%
2-Year Total Return
-78.57%
3-Year Total Return
-88.31%
5-Year Total Return
-90.72%
52-week Low
Aug 05, 2024 - $0.334
52-week High
Dec 23, 2024 - $1.65
Valuation
Market Cap
$21.79M - Nano Cap
Enterprise Value
-$4.95M
Price/Sales (TTM)
3.58
Price/Book (Q)
0.62
Dividends and Shares
Shares Outstanding
27.86M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sol-gel.com
Phone Number
972 8 931 3433
Address
7 Golda Meir Street
Ness Ziona, 7403650
Country
Israel
Year Founded
1997
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers... more
NASDAQ 04/25/2025 3:59PM Eastern Quotes delayed